Duearity AB reported sales results for the month of December 2023. For the period, the company reported sales amounted to SEK 450,000, which is the best sales result for a single month so far since the company received CE marking for the EU and FDA approval for the USA earlier this year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1156 SEK | -3.51% | -64.76% | -94.79% |
31/05 | Duearity AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
11/03 | Duearity Unit Signs US Distribution Deal With Westone Laboratories | MT |
1st Jan change | Capi. | |
---|---|---|
-94.79% | 302K | |
-5.06% | 28.92B | |
+28.27% | 8.15B | |
+26.15% | 4.27B | |
-29.97% | 2.53B | |
-9.44% | 1.63B | |
-19.04% | 1.41B | |
-34.19% | 1.14B | |
+4.19% | 904M | |
-41.37% | 838M |
- Stock Market
- Equities
- DEAR Stock
- News Duearity AB
- Duearity AB Reports Sales Results for the Month of December 2023